Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (481-490 of 752) with videos related to

Pageof 76
Sort By:
Basic Research in Cardiology|December 22, 2010
Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γSvitlana Demyanets, Christoph Kaun, Kathrin Rychli, et al.
Journal of Clinical Medicine|February 11, 2023
Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19Christoph C Kaufmann, Amro Ahmed, Marie Muthspiel, et al.
European Heart Journal|January 29, 2009
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of CardiologyWiktor Kuliczkowski, Adam Witkowski, Lech Polonski, et al.
International Journal of Cardiology|April 15, 2014
Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarctionChristopher Adlbrecht, Kurt Huber, Harmony R Reynolds, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Frequency and Impact of Bleeding on Outcome in Patients With Cardiogenic ShockAnne Freund, Alexander Jobs, Philipp Lurz, et al.
Nuclear Medicine Communications|November 22, 2014
¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activityDerk O Verschure, Tim C de Wit, Vivian Bongers, et al.
Atherosclerosis|December 3, 2014
Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery diseaseKonstantin A Krychtiuk, Stefan P Kastl, Stefan Pfaffenberger, et al.
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
The American Journal of Cardiology|August 24, 2018
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)Tomoya T Hinohara, Matthew T Roe, Harvey D White, et al.
Thrombosis and Haemostasis|March 25, 2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novelSteen Husted, Raffaele de Caterina, Felicita Andreotti, et al.
Pageof 76

Showing results (481-490 of 752) with videos related to

Sort By:
Pageof 76
Basic Research in Cardiology|December 22, 2010
Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γSvitlana Demyanets, Christoph Kaun, Kathrin Rychli, et al.
Journal of Clinical Medicine|February 11, 2023
Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19Christoph C Kaufmann, Amro Ahmed, Marie Muthspiel, et al.
European Heart Journal|January 29, 2009
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of CardiologyWiktor Kuliczkowski, Adam Witkowski, Lech Polonski, et al.
International Journal of Cardiology|April 15, 2014
Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarctionChristopher Adlbrecht, Kurt Huber, Harmony R Reynolds, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Frequency and Impact of Bleeding on Outcome in Patients With Cardiogenic ShockAnne Freund, Alexander Jobs, Philipp Lurz, et al.
Nuclear Medicine Communications|November 22, 2014
¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activityDerk O Verschure, Tim C de Wit, Vivian Bongers, et al.
Atherosclerosis|December 3, 2014
Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery diseaseKonstantin A Krychtiuk, Stefan P Kastl, Stefan Pfaffenberger, et al.
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
The American Journal of Cardiology|August 24, 2018
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)Tomoya T Hinohara, Matthew T Roe, Harvey D White, et al.
Thrombosis and Haemostasis|March 25, 2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novelSteen Husted, Raffaele de Caterina, Felicita Andreotti, et al.
Pageof 76